CVA Family Office’s Quest Diagnostics DGX Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $25.3K | Sell |
141
-23
| -14% | -$4.13K | ﹤0.01% | 647 |
|
2025
Q1 | $27.7K | Sell |
164
-4
| -2% | -$677 | ﹤0.01% | 632 |
|
2024
Q4 | $25.3K | Buy |
168
+35
| +26% | +$5.28K | ﹤0.01% | 636 |
|
2024
Q3 | $20.6K | Sell |
133
-1
| -0.7% | -$155 | ﹤0.01% | 652 |
|
2024
Q2 | $18.3K | Buy |
134
+4
| +3% | +$548 | ﹤0.01% | 655 |
|
2024
Q1 | $17.3K | Buy |
+130
| New | +$17.3K | ﹤0.01% | 665 |
|
2023
Q3 | – | Sell |
-5
| Closed | -$703 | – | 410 |
|
2023
Q2 | $703 | Buy |
+5
| New | +$703 | ﹤0.01% | 966 |
|
2022
Q3 | – | Sell |
-45
| Closed | -$6K | – | 884 |
|
2022
Q2 | $6K | Hold |
45
| – | – | ﹤0.01% | 715 |
|
2022
Q1 | $6K | Buy |
+45
| New | +$6K | ﹤0.01% | 744 |
|